Cargando…

A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas: The Example of 5-Aminolevulinic Acid Compared With White-Light Surgery

BACKGROUND: High-grade gliomas are aggressive, incurable tumors characterized by extensive diffuse invasion of the normal brain parenchyma. Novel therapies at best prolong survival; their costs are formidable and benefit is marginal. Economic restrictions thus require knowledge of the cost-effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Susana, Alves, Marta, Castel-Branco, Marta, Stummer, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neurosurgery 2015
Materias:	Research—Human—Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410964/ https://www.ncbi.nlm.nih.gov/pubmed/25714513 http://dx.doi.org/10.1227/NEU.0000000000000673

Ejemplares similares

A Data-Driven Approach to Predicting 5-Aminolevulinic Acid–Induced Fluorescence and World Health Organization Grade in Newly Diagnosed Diffuse Gliomas
por: Müther, Michael, et al.
Publicado: (2022)

Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
por: Jaber, Mohammed, et al.
Publicado: (2019)

The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, (18)F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors
por: Jaber, Mohammed, et al.
Publicado: (2015)

Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas
por: Stummer, Walter, et al.
Publicado: (2017)

5-Aminolevulinic Acid Fluorescence-Guided Resection of (18)F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma
por: Müther, Michael, et al.
Publicado: (2019)

5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging
por: Stummer, Walter, et al.
Publicado: (2013)

5-ALA fluorescence in indeterminate grade gliomas
por: Müther, Michael, et al.
Publicado: (2022)

Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery—review of the literature
por: Suero Molina, Eric, et al.
Publicado: (2017)

5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns
por: Puppa, Alessandro Della, et al.
Publicado: (2014)

LGG-06. LONG-TERM OUTCOME OF NEWLY DIAGNOSED LOW GRADE GLIOMA
por: Sirachainan, Nongnuch, et al.
Publicado: (2020)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

SURG-08. 5-Aminolevulinic acid (5-ALA)-guided resection of pediatric brain tumors
por: Schwake, Michael, et al.
Publicado: (2022)

High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

Distinct Slow-Wave Activity Patterns in Resting-State Electroencephalography and Their Relation to Language Functioning in Low-Grade Glioma and Meningioma Patients
por: Wolthuis, Nienke, et al.
Publicado: (2022)

Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery
por: Schatlo, Bawarjan, et al.
Publicado: (2015)

Effect of 5-Aminolevulinic Acid and Sodium Fluorescein on the Extent of Resection in High-Grade Gliomas and Brain Metastasis
por: Ahrens, Lasse Cramer, et al.
Publicado: (2022)

Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma
por: Wang, Linda M., et al.
Publicado: (2021)

Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas
por: Liu, Yanwei, et al.
Publicado: (2021)

Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome
por: Schebesch, Karl-Michael, et al.
Publicado: (2022)

HGG-19. 5-AMINOLEVULINIC ACID (5-ALA)-GUIDED RESECTION OF PEDIATRIC BRAIN TUMORS
por: Schwake, Michael, et al.
Publicado: (2021)

Infrared Thermography in Surgery of Newly Diagnosed Glioblastoma Multiforme: A Technical Case Report
por: Naydenov, Emanuil, et al.
Publicado: (2017)

Deep proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-aminolevulinic acid
por: Ghantasala, Saicharan, et al.
Publicado: (2023)

Comment on Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540
por: Stummer, Walter, et al.
Publicado: (2021)

Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas
por: Qaddoumi, Ibrahim, et al.
Publicado: (2014)

Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas()
por: Luks, Tracy L., et al.
Publicado: (2018)

Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2018)

Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells
por: Jalili-Nik, Mohammad, et al.
Publicado: (2021)

Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study
por: Teixidor, Pilar, et al.
Publicado: (2016)

Fluorescence-Guided High-Grade Glioma Surgery More Than Four Hours After 5-Aminolevulinic Acid Administration
por: Maragkos, Georgios A., et al.
Publicado: (2021)

THE USE OF 5-AMINOLEVULINIC ACID (5-ALA) IN HIGH-GRADE GLIOMA SURGERY, A SINGLE CANADIAN CENTER EXPERIENCE
por: LeBlanc, Félix, et al.
Publicado: (2023)

Fluorescein in brain metastasis and glioma surgery
por: Stummer, Walter
Publicado: (2015)

“My family doctor didn’t know how to help me”: a teenager’s perspective on being diagnosed with long COVID
por: Saigle, Victoria
Publicado: (2023)

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

Prognostic value of (18)F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma
por: Dissaux, Gurvan, et al.
Publicado: (2020)

High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas
por: Zhang, Jie, et al.
Publicado: (2021)

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
por: Gallia, Gary L, et al.
Publicado: (2020)

High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase
por: Liu, Yanwei, et al.
Publicado: (2021)

Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas
por: Carrete, Luis R., et al.
Publicado: (2022)

EPCT-16. A PHASE IB STUDY OF PTC596 IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA AND HIGH GRADE GLIOMA
por: Smiley, Natasha Pillay, et al.
Publicado: (2020)

Beyond the White Coat Ceremony
por: Salameh, Maya
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_e7df41qc44luvn15c4m1np3jkf